Verition Fund Management’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-24,887
Closed -$560K 2710
2024
Q4
$560K Buy
24,887
+14,277
+135% +$321K ﹤0.01% 1828
2024
Q3
$271K Buy
+10,610
New +$271K ﹤0.01% 2030